Loading...
XNAS
PGNY
Market cap1.96bUSD
Apr 02, Last price  
22.98USD
1D
-0.48%
1Q
29.61%
IPO
33.53%
Name

Progyny Inc

Chart & Performance

D1W1MN
XNAS:PGNY chart
No data to show
P/E
36.12
P/S
1.68
EPS
0.64
Div Yield, %
Shrs. gr., 5y
2.69%
Rev. gr., 5y
38.42%
Revenues
1.17b
+7.22%
48,584,000105,400,000229,683,000344,858,000500,621,000786,913,0001,088,598,0001,167,221,000
Net income
54m
-12.41%
-12,452,000661,000-8,569,00046,459,00065,769,00030,358,00062,037,00054,336,000
CFO
179m
-5.14%
-9,474,0002,272,000-1,534,00036,203,00026,037,00080,395,000188,814,000179,105,000
Earnings
May 07, 2025

Profile

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
IPO date
Oct 25, 2019
Employees
393
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑12
Income
Revenues
1,167,221
7.22%
1,088,598
38.34%
786,913
57.19%
Cost of revenue
1,099,766
1,026,414
763,572
Unusual Expense (Income)
NOPBT
67,455
62,184
23,341
NOPBT Margin
5.78%
5.71%
2.97%
Operating Taxes
28,866
8,654
(5,917)
Tax Rate
42.79%
13.92%
NOPAT
38,589
53,530
29,258
Net income
54,336
-12.41%
62,037
104.35%
30,358
-53.84%
Dividends
Dividend yield
Proceeds from repurchase of equity
(300,278)
(11,072)
(9,016)
BB yield
18.24%
0.30%
0.29%
Debt
Debt current
2,859
2,149
1,231
Long-term debt
35,685
36,631
12,964
Deferred revenue
Other long-term liabilities
(3,016)
Net debt
(189,410)
(332,307)
(175,105)
Cash flow
Cash from operating activities
179,105
188,814
80,395
CAPEX
(5,405)
(3,644)
(3,241)
Cash from investing activities
195,792
(200,525)
(43,866)
Cash from financing activities
(309,880)
(11,072)
(7,864)
FCF
43,293
41,718
(17,907)
Balance
Cash
227,954
371,087
189,300
Long term investments
Excess cash
169,593
316,657
149,954
Stockholders' equity
48
92,799
28,444
Invested Capital
441,286
480,020
353,221
ROIC
8.38%
12.85%
9.50%
ROCE
15.28%
10.86%
6.07%
EV
Common stock shares outstanding
95,448
100,672
99,957
Price
17.25
-53.60%
37.18
19.36%
31.15
-38.13%
Market cap
1,646,484
-56.01%
3,743,000
20.21%
3,113,666
-38.38%
EV
1,457,074
3,410,693
2,938,561
EBITDA
70,630
64,465
24,942
EV/EBITDA
20.63
52.91
117.82
Interest
814
Interest/NOPBT
3.49%